Flexion Therapeutics

Transformative Medicine... Where It Matters

  • COVID-19 Update
  • Who We Are
    • Core Principles & Values
    • Executive Committee
    • Board of Directors
    • Corporate Social Responsibility
  • Our Product
  • Our Pipeline
    • FX201
    • FX301
  • Our Science
    • Unmet Need in Osteoarthritis
    • Clinical Trials and Associated Publications
  • News
    • Press Releases
  • Investors
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Analyst Coverage
    • Contact Us
  • Careers
    • Our Culture
    • Benefits
  • Contact
    • Medical Information Request Form
    • Partnering
    • Patient Expanded Access
    • Report a Compliance Matter
  • COVID-19 Update

Who We Are

Flexion HQ Exterior

Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis.

Nasdaq Tower

We embrace a philosophy of scientific entrepreneurship which spurs innovation and empowers and inspires our people to discover, develop and commercialize transformative therapies which can make a meaningful difference in the lives of patients.

Flexion was co-founded in 2007 by Michael Clayman, M.D., and Neil Bodick, M.D., Ph.D., who leveraged the extensive drug development expertise they gained over decades at Eli Lilly and Company.

The company’s executive committee is comprised of industry veterans with deep knowledge, vast experience and the diverse leadership skills required in the biopharma industry.

  • Who We Are
    • Core Principles & Values
    • Executive Committee
    • Board of Directors
    • Corporate Social Responsibility
  • Our Product
  • Our Pipeline
    • FX201
    • FX301
  • Our Science
    • Unmet Need in Osteoarthritis
    • Clinical Trials and Associated Publications
  • News
    • Press Releases
  • Investors
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Analyst Coverage
    • Contact Us
  • Careers
    • Our Culture
    • Benefits
  • Contact
    • Medical Information Request Form
    • Partnering
    • Patient Expanded Access
    • Report a Compliance Matter
  • COVID-19 Update

© 2021, Flexion Therapeutics Inc.

781.305.7777

Website Design & Development by Graphic Beans

Terms of Use Sitemap Privacy Policy

Connect with us: LinkedIn-whiteTwitter-whiteGlassdoor-white